Advertisement Endocare names new interim president and CEO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Endocare names new interim president and CEO

Endocare, a medical device company, has appointed independent director Terrence Noonan as the interim president and interim CEO replacing Craig Davenport, the company's former chairman, president and CEO, who resigned to assume the CEO position with a privately held healthcare company.

Mr Noonan’s business career spans more than 30 years including 13 years in senior management roles with Laguna Niguel, a medical and industrial polymer components manufacturer.

Mr Noonan’s most recent position at Furon was as its president and COO from 1991 to 1999. Mr Noonan has served on the Endocare board of directors as lead independent director since June 2004.

The company has also announced that it is actively evaluating succession alternatives and continues to explore and evaluate potential strategic opportunities aimed at enhancing stockholder value and solidifying the long-term prospects of its cryoablation technology in the marketplace.

Mr Noonan said: “Craig successfully led the company’s efforts to grow its cryoablation business, re-establish full financial reporting compliance and relist the company’s stock on the NASDAQ capital market. On behalf of the board, we would like to thank Craig for his nearly five years of service and we all wish him well in his new endeavors.”